http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102861031-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90dd0196e1bf2c64c8fcbe74cef0b29c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b598a1342067a3dc78c71ce88dbdb6 |
| publicationDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102861031-B |
| titleOfInvention | Application of Gypensapogenin B in medicine for resisting respiratory syncytial virus |
| abstract | The invention relates to application of Gypensapogenin B in preparing a medicine for resisting respiratory syncytial viruses. The experiments prove that Gypensapogenin B has outstanding inhibiting effect on respiratory syncytial viruses (RSV). The invention provides experiment basis for that Gypensapogenin B is used for clinically treating infectious diseases of respiratory syncytial viruses (RSV), and provides a certain guiding meaning for preparing the medicine for resisting respiratory syncytial viruses (RSV), as well as has an important reference value. |
| priorityDate | 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.